THERAPIES K: what changed
THERAPIES K
Largest movements
- Tangible fixed assets -€21,360
no longer reported in 2025 (was €21,360)
- Cash -€3,057
down €3,057 (-84.7%), from €3,610 to €553
mainly Other debts (-€19,385) and Current portion of long-term debt (-€6,196)
- Deferred charges and accrued income -€498
down €498 (-84.7%), from €588 to €90
- Other debts -€19,385
down €19,385 (-84.0%), from €23,073 to €3,688
- Current portion of long-term debt -€6,196
no longer reported in 2025 (was €6,196)
- Profit (loss) carried forward +€3,835
up €3,835 (+14.8%), from -€25,948 to -€22,113
- Debts after one year -€2,606
no longer reported in 2025 (was €2,606)
- Trade debts -€365
down €365 (-59.9%), from €609 to €244
- Depreciation -€10,218
no longer reported in 2025 (was €10,218)
- Other operating charges +€4,685
up €4,685 (+396%), from €1,184 to €5,869
- Gross operating margin +€2,903
up €2,903 (+39.6%), from €7,323 to €10,226
- Taxes -€199
down €199 (-47.0%), from €422 to €224
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €25,558 | €643 | -€24,915 | -97.5% |
| Fixed assets | 21/28 | €21,360 | - | -€21,360 | |
| Intangible fixed assets | 21 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €21,360 | - | -€21,360 | |
| Furniture and vehicles | 24 | €21,360 | - | -€21,360 | |
| Current assets | 29/58 | €4,198 | €643 | -€3,555 | -84.7% |
| Cash at bank and in hand | 54/58 | €3,610 | €553 | -€3,057 | -84.7% |
| Deferred charges and accrued income | 490/1 | €588 | €90 | -€498 | -84.7% |
| Total equity and liabilities | 10/49 | €25,558 | €643 | -€24,915 | -97.5% |
| Equity | 10/15 | -€7,348 | -€3,513 | +€3,835 | +52.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€25,948 | -€22,113 | +€3,835 | +14.8% |
| Amounts payable | 17/49 | €32,906 | €4,155 | -€28,750 | -87.4% |
| Amounts payable after more than one year | 17 | €2,606 | - | -€2,606 | |
| Financial debts | 170/4 | €2,606 | - | -€2,606 | |
| Amounts payable within one year | 42/48 | €30,300 | €4,155 | -€26,145 | -86.3% |
| Current portion of amounts payable after more than one year | 42 | €6,196 | - | -€6,196 | |
| Trade debts | 44 | €609 | €244 | -€365 | -59.9% |
| Suppliers | 440/4 | €609 | €244 | -€365 | -59.9% |
| Taxes, remuneration and social security | 45 | €422 | €224 | -€199 | -47.0% |
| Taxes | 450/3 | €422 | €224 | -€199 | -47.0% |
| Other amounts payable | 47/48 | €23,073 | €3,688 | -€19,385 | -84.0% |
| Accrued charges and deferred income | 492/3 | - | €0 | +€0 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,218 | - | -€10,218 | |
| Other operating charges | 640/8 | €1,184 | €5,869 | +€4,685 | +396% |
| Gross operating margin | 9900 | €7,323 | €10,226 | +€2,903 | +39.6% |
| Operating profit (loss) | 9901 | -€4,079 | €4,357 | +€8,436 | |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €323 | €298 | -€25 | -7.8% |
| Recurring financial charges | 65 | €323 | €298 | -€25 | -7.8% |
| Profit (loss) for the period before taxes | 9903 | -€4,402 | €4,059 | +€8,461 | |
| Income taxes | 67/77 | €422 | €224 | -€199 | -47.0% |
| Profit (loss) for the period | 9904 | -€4,824 | €3,835 | +€8,660 | |
| Profit (loss) for the period to be appropriated | 9905 | -€4,824 | €3,835 | +€8,660 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.